EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Predicting the risk of treatment‐requiring retinopathy of prematurity in preterm infants in Greece. External validation of DIGIROP prognostic models

Stella Moutzouri iD, Aldina Pivodic iD, Anna-Bettina Haidich, Aikaterini K Seliniotaki, Maria Lithoxopoulou, Christos Tsakalidis, Ann Hellström iD, Nikolaos Ziakas, Asimina Mataftsi iD

Acta Ophthalmologica · 2025

DOI: 10.1111/aos.16788 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von Stella Moutzouri und 8 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Ophthalmology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Infant, Premature, Neonatal Screening. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the predictive performance of DIGIROP‐v1.0 models in identifying treatment‐requiring ROP among infants undergoing ROP screening at a tertiary neonatal intensive care unit in Greece.

Methods

Retrospective cohort analysis of 640 consecutive screened preterm infants with gestational age (GA) 24 0/7 to 30 6/7 weeks and known ROP outcome in the 2nd Neonatology Department of Aristotle University of Thessaloniki (2009–2021). The primary outcome was the development of type 1 ROP according to the Early Treatment of ROP criteria or treatment based on the ophthalmologist's judgement. Sensitivity, specificity, area under the curve (AUC) with corresponding 95% confidence intervals (CI) and calibration plots for the DIGIROP‐v1.0 models were displayed.

Results

The DIGIROP‐Birth‐v1.0 model correctly identified 35/43 treated infants (sensitivity 81.4% [95% CI, 66.6%–91.6%], specificity 61.5% [95% CI, 57.4%–65.4%], AUC 0.82 [95% CI, 0.75–0.90]). During the postnatal weeks 6–14 the sensitivity of the DIGIROP‐Screen‐v1.0 model ranged from 82.6% to 100%. Eleven infants, all with severe comorbidities, that is, congenital malformation(s), syndrome(s), hydrocephalus or history of intestinal surgery, that were treated, were missed by the model, but met criteria for screening according to DIGIROP‐v1.0 models' recommendations, and to our unit's routine standards.

Conclusion

The DIGIROP‐v1.0 models resulted in lower sensitivity and higher specificity in this Greek cohort compared with the Swedish development group. Despite higher GA and BW, infants in our cohort had higher incidence of treated ROP than in Sweden, resulting in an under‐estimation of their risk for treatment‐requiring ROP. Further validation of the DIGIROP‐v2.0 models and potential adjusting are recommended to maximize generalizability in populations with different characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinopathy of PrematurityInfant, PrematureNeonatal ScreeningHumansInfant, NewbornRetrospective StudiesGreeceFemaleMaleGestational AgePrognosisRisk AssessmentRisk FactorsIncidenceFollow-Up StudiesIntensive Care Units, Neonatal

Stichwörter der Autor:innen

paediatric ophthalmologyprognosisprognostic model(s)retinaretinopathy of prematurity

Autor:innen und Institutionen

  • 2nd Department of Ophthalmology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Ophthalmology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Hygiene, Social-Preventive Medicine & Medical Statistics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • 2nd Department of Neonatology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

ORCID-Profile: Stella Moutzouri, Aldina Pivodic, Ann Hellström, Asimina Mataftsi

Zitieren

APA

Moutzouri, S., Pivodic, A., Haidich, A. B., Seliniotaki, A. K., Lithoxopoulou, M., Tsakalidis, C., Hellström, A., Ziakas, N., & Mataftsi, A. (2025). Predicting the risk of treatment‐requiring retinopathy of prematurity in preterm infants in Greece. External validation of DIGIROP prognostic models. Acta Ophthalmologica. https://doi.org/10.1111/aos.16788

Vancouver

Moutzouri S, Pivodic A, Haidich AB, Seliniotaki AK, Lithoxopoulou M, Tsakalidis C, et al. Predicting the risk of treatment‐requiring retinopathy of prematurity in preterm infants in Greece. External validation of DIGIROP prognostic models. Acta Ophthalmologica. 2025. doi:10.1111/aos.16788

BibTeX
@article{Moutzouri2025,
  author = {Moutzouri, Stella and Pivodic, Aldina and Haidich, Anna-Bettina and Seliniotaki, Aikaterini K and Lithoxopoulou, Maria and Tsakalidis, Christos and Hellström, Ann and Ziakas, Nikolaos and Mataftsi, Asimina},
  title = {Predicting the risk of treatment‐requiring retinopathy of prematurity in preterm infants in Greece. External validation of DIGIROP prognostic models},
  journal = {Acta Ophthalmologica},
  year = {2025},
  doi = {10.1111/aos.16788}
}
Kostenlos starten →